- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.10. | OSTEOPORE LIMITED: Resignation and appointment of Company Secretary | - | ASX | ||
| 09.09. | OSTEOPORE LIMITED: OSX secures market access to Thailand orthopaedic market | 1 | ASX | ||
| OSTEOPORE Aktie jetzt für 0€ handeln | |||||
| 31.08. | Osteopore Ltd H1 Sales Decline | 1 | RTTNews | ||
| 31.08. | OSTEOPORE LIMITED: Half Yearly Report and Accounts | 1 | ASX | ||
| 06.08. | Daily Special: Chilwa Minerals, Osteopore, DeSoto Resources, Sabre Resources, Somerset Minerals | 5 | Finance News Network | ||
| 06.08. | Osteopore (ASX:OSX) signs 3-year GCC deal targeting a US$1.55bn orthopaedic market | - | Stocks Down Under | ||
| 06.08. | OSTEOPORE LIMITED: OSX strikes orthopaedic deal for 5 Middle East countries | 1 | ASX | ||
| 03.08. | OSTEOPORE LIMITED: Details of Auditor Appointment/Resignation | - | ASX | ||
| 03.08. | OSTEOPORE LIMITED: OSX completes first Hainan custom orthopaedic implant | 1 | ASX | ||
| 31.07. | OSTEOPORE LIMITED: Activities Report June 2026 and Appendix 4C | 1 | ASX | ||
| 23.07. | OSTEOPORE LIMITED: Application for quotation of securities - OSX | - | ASX | ||
| 14.07. | OSTEOPORE LIMITED: First OSX custom orthopaedic implant delivered to Hainan | - | ASX | ||
| 07.07. | OSTEOPORE LIMITED: OSX & Zimmer gain craniofacial market access to Saudi Arabia | - | ASX | ||
| 02.07. | OSTEOPORE LIMITED: OSX completes co-development project for neurosurgical guide | - | ASX | ||
| 30.06. | OSTEOPORE LIMITED: First patient treated in OSX-PAH jaw reconstruction trial | - | ASX | ||
| 29.06. | OSTEOPORE LIMITED: First 2 patients treated in QCH cleft lip clinical trial | - | ASX | ||
| 26.06. | Osteopore wraps up recruitment into 3D printing support for cleft lip patients | 1 | The Market Online Australia | ||
| 26.06. | OSTEOPORE LIMITED: QCH cleft lip clinical study patient recruitment completed | - | ASX | ||
| 24.06. | OSTEOPORE LIMITED: OSX neuro products approved in a major centre in Thailand | - | ASX | ||
| 23.06. | OSTEOPORE LIMITED: Cleansing Notice | - | ASX |
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 41,840 | +0,19 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,86 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS | 45,560 | +0,56 % | Fresenius: Mahl übernimmt Kabi - Hennicken bleibt bis 2032 | Marc-Alexander Mahl zieht zum 1. November 2026 in den Vorstand von Fresenius ein und übernimmt dort die Verantwortung für Fresenius Kabi. Der 58-Jährige folgt auf Pierluigi Antonelli, der den Konzern... ► Artikel lesen | |
| HEARTFLOW | 55,44 | +0,01 % | Piper Sandler raises HeartFlow stock price target on competitive moat | ||
| FRESENIUS MEDICAL CARE | 40,020 | +2,14 % | FMC-Aktie im Minus: US-Reformpläne setzen Dialyse-Giganten unter Druck | Ein Kursrutsch erschüttert Fresenius Medical Care, nachdem US-Reformpläne für Wirbel sorgen. Experten warnen vor fundamentalen Risiken für das Geschäftsmodell des DAX-Konzerns. So prognostiziert das... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,565 | +0,04 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| CONCENTRA GROUP | 39,970 | 0,00 % | Stephens initiates Concentra stock with overweight on health model | ||
| PROGYNY | 29,120 | 0,00 % | Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report | ||
| AVEANNA HEALTHCARE | 13,310 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,010 | -0,10 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 28,310 | 0,00 % | Kestra Medical Technologies: Evercore-Einstufung treibt Aktie vorbörslich an | ||
| ALIGNMENT HEALTHCARE | 8,430 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Adds New Medicare Advantage Plan in Pima County, Increasing Access and Choice for Arizona Seniors | ||
| GENEDX | 67,26 | 0,00 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| BILLIONTOONE | 105,67 | -0,01 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 22,890 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |
OSTEOPORE LIMITED gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu OSTEOPORE LIMITED finden Sie auf Wallstreet Online.